SG Americas Securities
GALT icon

SG Americas Securities’s Galectin Therapeutics GALT Stock Holding History

SG Americas Securities’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,935
Closed -$18K – 3567
2024
Q4 		$18K Buy
+13,935
New +$33.4K ﹤0.01% 3017
2020
Q3 		– Sell
-20,418
Closed -$62K – 2973
2020
Q2 		$62K Buy
20,418
+7,542
+59% +$19K ﹤0.01% 3500
2020
Q1 		$25K Buy
+12,876
New +$31.3K ﹤0.01% 3279
2014
Q3 		– Sell
-24,744
Closed -$342K – 2709
2014
Q2 		$342K Buy
+24,744
New +$308K ﹤0.01% 1821

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return